The largest database of trusted experimental protocols

Synergy 2 microplate reader

Manufactured by Agilent Technologies
Sourced in United States, Germany, United Kingdom, Switzerland

The Synergy 2 microplate reader is a multi-mode microplate reader designed for a variety of quantitative and qualitative analyses. It features multiple detection modes, including absorbance, fluorescence, and luminescence, to accommodate a wide range of assays and applications.

Automatically generated - may contain errors

479 protocols using synergy 2 microplate reader

1

Ostarine's Effects on Cell Viability and Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded onto a 96-well plate and cultured in a standard culture medium for 24 h. Then, cells were washed in PBS, and the medium was changed to experimental (DMEM with 0.2% BSA), supplemented with different concentrations of ostarine, and cultured for the next 24 h. Some cells were grown in standard medium as a positive control.
After 24 h, to investigate viability, cells were treated with MTT solution ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) for 1 h. Then, the medium was removed, and 100 μL of DMSO was added to the cells to dissolve the formazan crystals. The optical density was measured using a Synergy 2 microplate reader (BioTek Instruments, Winooski, VT, USA).
Cell Proliferation ELISA BrdU colorimetric kit (Roche Diagnostics, Penzberg, Germany) was used to test proliferation by evaluating the incorporation of bromodeoxyuridine (BrdU) into new DNA strands of proliferating cells. After 21 h incubation with the examined concentrations of ostarine, BrdU solution (10 μM) was added for 3 h. The assay was performed according to the manufacturer’s instructions. The optical density of these samples was also measured using a Synergy 2 microplate reader (BioTek Instruments, Winooski, VT, USA).
+ Open protocol
+ Expand
2

Cell Viability and Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 96-well clear, flat-bottom plates (Microtest 96, Falcon, Corning, NY, USA) at a density of 500 cells per well. Each plate was incubated overnight at 37 °C under 5% CO2. R1881 and bicalutamide were dissolved in DMSO and diluted to the appropriate concentrations to a total volume of 100 μL and 0.1% DMSO per well. The cells were then incubated for at 37 °C. Cell viability was assessed by Celltiter-Blue assay kit (Promega, Madison, WI, USA) as instructed by the manufacturer. After treatment, cells were incubated with CellTiter-Blue® reagent for 1 h at 37 °C. Fluorescence was measured on a BioTek Synergy 2 microplate reader (BioTek, Winooski, VT, USA) at 560/590 nM. For sulforhodamine B (SRB) assays, MOE cells were plated at 5 × 103 cells/mL in a 96-well plate then treated and incubated for 5 days followed by colorimetric assay as described previously [35 (link)]. Absorbance at 505 nM was measured on a BioTek Synergy 2 microplate reader.
+ Open protocol
+ Expand
3

Quantifying Drug Encapsulation in PLGA Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NPs’ loading capacity
(LC) and encapsulation efficiency
(EE) were obtained indirectly by quantifying the unloaded drug in
the supernatant.
Free TMZ was quantified by fluorescence at
excitation and emission wavelengths of 420 and 540 nm, respectively
(Synergy 2 microplate reader, BioTek, UK). UV–vis absorbance
measurements quantified free BTZ at λmax = 269 nm
(Synergy 2 microplate reader, BioTek, U.K.). The obtained absorbance
and fluorescence values were correlated to the BTZ and TMZ calibration
curves in PVA, respectively.
The EE values were expressed as
the percentage of the entrapped
drug to the total used drug. The LC of the NPs was given as the percentage
of the entrapped drugs to the PLGA weight.
+ Open protocol
+ Expand
4

Triglyceride Analysis in Follicular Fluid

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triglyceride concentrations in follicular fluid samples were determined using a colorimetric assay kit (Cayman Chemical, Ann Harbor, MI, USA) according to kit instructions. The 96-well, non-treated microplate was read at 540-nm absorbance on a Synergy 2 microplate reader (Biotek, Agilent, Santa Clara, CA, USA). All samples were assayed on a single plate. The intra-assay coefficient of variation was 1.35%, and the minimal detectable concentration was 1 mg/dL. Concentrations of non-esterified free fatty acids and insulin in follicular fluid were determined by a reference laboratory (Clinical Pathology Laboratory, Cornell University Animal Health Diagnostic Center, Ithaca, NY). Analyses of follicular fluid acylcarnitine profiles were conducted by a reference laboratory (University of Colorado Anschutz Medical Campus School of Medicine Metabolomics Core, Aurora, CO, USA) as previously described92 (see Appendix A.2 for the detailed method).
+ Open protocol
+ Expand
5

BMSCs Viability Assay with BBR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BMSCs cells were seeded into 96-well plates (5,000 cells per well) and cultured overnight, then treated with BBR at different concentrations (0, 1, 5, 10, 50 and 100 µM) at 37°C for 72 h. Cell viability was measured using the CCK-8 kit according to the manufacturer's protocol. After removing the supernatant, fresh growth medium containing CCK-8 (Vcck-8:Vmedium, 1:10) was added into each well and incubated at 37°C for 2 h. The absorbance of the samples was measured at 450 nm using a Synergy 2 microplate reader (Agilent Technologies, Inc.).
+ Open protocol
+ Expand
6

Lipid Peroxidation Biomarkers in Rat SN

Check if the same lab product or an alternative is used in the 5 most similar protocols
Malondialdehyde (MDA) and GSH were chosen as lipid peroxidation detection indices. The two indices were tested in the rat SN using an MDA kit (Cat# A003-1-2, Nanjing Jiancheng Bioengineering Institute, Nanjing, China) and a GSH kit (Nanjing Jiancheng Bioengineering Institute, Cat# A006-1). The optical densities at 532 nm for MDA and 420 nm for GSH were measured with a Synergy 2 microplate reader (Agilent Technologies, Inc.). Each sample were measured three times, and the average absorbance values were calculated for every sample. A standard curve of MDA and GSH were generated. The concentration of MDA and GSH in the samples was calculated using the standard curve.
+ Open protocol
+ Expand
7

Cytokine and Basement Membrane Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Relative cytokine levels were determined using a sandwich immunoassay array from RayBiotech, Inc. (Human Cytokine Antibody Array C Series 1000, Inc, GA, USA). Chemilumenescence was detected using a Foto/Analyst Luminaryfx Workstation (Fotodyne Incorporated, WI, USA) and the signal intensities were measured using TotalLab 100 software (Nonlinear Dynamics, Ltd, UK). The relative abundance of basement membrane and immune related biomolecules was performed (with 4 pooled samples) by MSBioworks (Ann Arbor, MI) using nano LC/MS/MS with a Waters NanoAcquity HPLC (Waters, Milford, MA) system interfaced to a Orbitrap Velos Pro (ThermoFisher, Waltham, MA). Proteins were identified from primary sequence databases using Mascot database search engine (Boston, MA). Total protein content was determined using a micro BCA protein assay (Pierce, Rockford, IL), and measured at 562 nm using a Synergy II microplate reader (BioTek, Winooski, VT).
+ Open protocol
+ Expand
8

IP₃ ELISA Quantification in hVSMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
IP3 enzyme-linked immunosorbent assays were purchased from LS Bio and performed as per the manufacturer's protocol (LS BIO F10644). In brief, hVSMCs were grown to confluency in six-well dishes (Nunc) and then treated as described in the Results section. Cells were then washed once with cold PBS, 225 µl of cold PBS was added to each well and cells were lysed by ultrasonication. The cell lysate was centrifuged for 10 min at 4°C at 1500g to remove cellular debris. The total protein concentration in the supernatant was determined with the Bio-Rad DC Protein Assay as per the manufacturer's protocol (Bio-Rad 500-0116). Equivalent amounts of total protein were added to the ELISA strips diluted in the provided sample diluent (1 : 5 and 1 : 10). The assay was then completed as per the manufacturer's protocol. Optical densities were read on a Biotek Synergy II microplate reader (absorbance at 450 nm), and IP3 concentrations were extrapolated from the standard curve.
+ Open protocol
+ Expand
9

Alamar Blue Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured using alamarBlue assay according to the manufacturer’s recommendations (AbD Serotec, Raleigh, NC, U.S.A.). In brief, we cultured cells in 96-well plates in 100 μl of the appropriate medium and at the indicated time point, and 10 μl of alamarBlue substrate was added and plates were incubated in the dark at 37°C for 1 h. Reading was subsequently taken using fluorescent mode (Ex 530 nm/Em 590 nm) using BioTek Synergy II microplate reader (BioTek Inc., Winooski, VT, U.S.A.).
+ Open protocol
+ Expand
10

Paclitaxel Combination Therapy in OVCAR5 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vitro studies in OVCAR5 cells were performed as previously described in (13 (link)). OVCAR5 cells (ATCC) were seeded in 96-well plates (Corning Costar Cat.# 3917) in media containing 2.5% FBS (Charles River Laboratories). After 48 hours, paclitaxel (Sigma-Aldrich) ± 100 nmol/L dexamethasone (Sigma-Aldrich) ± 450 nmol/L relacorilant were added. After another 72 hours, 100 μL of Cell Titer-Glo (Promega) reagent was added to each well and luminescence was quantified on the Synergy II microplate reader (BioTek). Data were normalized to controls, either equivalent volumes of dimethyl sulfoxide or empty wells. A non-parametric t test was conducted to compare normalized percentage of viability at 1,000 nmol/L paclitaxel, 100 nmol/L dexamethasone, ± 450 nmol/L relacorilant using Microsoft Excel. Charles River Laboratories study number: e533.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!